Table 4.
Outcome | Instrument | Main components | Reference |
---|---|---|---|
Disease activity | Composite measures | ||
ACR 20, 50, 70 response | Percentage improvement in tender and swollen joint counts in addition to improvement in three out of five measures: physician's and patient's assessment of disease activity, patient's assessment of pain, acute phase reactant, and functional questionnaire | [116] | |
PsARC | Improvement by >1 point in both physician's and patient's assessment of disease activity in addition to >30% reduction in tender and swollen joint counts | [117] | |
Skin disease | |||
PASI 50, 75 | Percentage improvement in severity and extent of skin involvement | [118] | |
Minimal disease activity | Having five of the following seven criteria: tender joint count <1; swollen joint count <1; PASI <1 or body surface area <3; patient pain VAS <15; patient global disease activity VAS <20; health assessment questionnaire <0.5; and tender entheseal points <1 | [119] | |
Radiograph scoring | Sharp score | Joint erosion + joint narrowing scores | [120] |
ACR, American College of Rheumatology; PASI, Psoriasis Area and Severity Index; PsARC, Psoriatic Arthritis Response Criteria; VAS, visual analogue scale.